Metal-phenolic nanocatalyst rewires metabolic vulnerability for catalytically amplified ferroptosis

Ferroptosis is associated with excessive lipid peroxidation (LPO) accumulation, followed by membrane fragmentation. Although lipid metabolism is essential for regulating ferroptosis execution in tumors, there has been no use of nanomedicine to modulate the effect of metabolic vulnerability on ferroptosis. This study presents a metal-phenolic nanocatalyst (Fe@MT nanocatalyst), self-assembled using ferric ions (Fe3+) and coordinating with mitoxantrone (MT). This nanocatalyst accumulates lipid peroxides to strengthen ferroptotic vulnerability by initiating reactive oxygen species (ROS) storm and remodeling polyunsaturated fatty acids (PUFAs)-containing lipid metabolism. Fe@MT nanocatalyst catalytically converts endogenous hydrogen peroxide into highly active hydroxyl radical and depletes high intracellular levels of glutathione upon its internalization by U87MG cells, resulting in the release of MT, which in return promotes irreversible ferroptosis by elevating the intracellular production of ROS-sensitive PUFAs and inducing lethal LPO. Fe@MT nanocatalyst exhibits near-infrared photothermal property because of Fe3+ and MT self-assembly, causing photothermal-amplified catalytic ferroptosis therapy. This study sheds new light on promoting the sensitivity and execution of ferroptosis by reinforcing lethal lipid metabolism and accumulating excessive LPO and will establish an exploitable interaction between ferroptosis and lipid metabolic vulnerability in cancer.